Data Presented at the American Psychiatric Association Annual Meeting Supports ... - MarketWatch (press release)
Posted by admin / Under ZolpidemData Presented at the American Psychiatric Association Annual Meeting Supports ... MarketWatch (press release) PHILADELPHIA, May 8, 2012 /PRNewswire via COMTEX/ -- The new prescription sleep aid Intermezzo (zolpidem tartrate) sublingual tablet CIV is the first and only prescription sleep aid approved by the US Food and Drug Administration (FDA) for the ... |
Published on Friday 18th of May 2012 02:23:11 PM
Read more...
Data Presented at the American Psychiatric Association Annual Meeting Supports ... - PR Newswire (press release)
Posted by admin / Under ZolpidemData Presented at the American Psychiatric Association Annual Meeting Supports ... PR Newswire (press release) PHILADELPHIA, May 8, 2012 /PRNewswire/ -- The new prescription sleep aid Intermezzo (zolpidem tartrate) sublingual tablet CIV is the first and only prescription sleep aid approved by the US Food and Drug Administration (FDA) for the treatment of ... |
Published on Friday 18th of May 2012 02:23:11 PM
Read more...
Unlicensed doctor charged with health care fraud - Topeka Capital Journal
Posted by admin / Under ZolpidemUnlicensed doctor charged with health care fraud Topeka Capital Journal She also is accused of illegally writing prescriptions for such controlled substances as Zolpidem, Hydrocodone, Alprazolam and Phentermine using her father's Drug Enforcement Administration registration number. AP contributed to this report. |
Published on Friday 18th of May 2012 02:23:11 PM
Read more...
Par Pharmaceutical Companies Reports First Quarter 2012 Results - MarketWatch (press release)
Posted by admin / Under ZolpidemPar Pharmaceutical Companies Reports First Quarter 2012 Results MarketWatch (press release) Zolpidem Tartrate: Net sales of zolpidem tartrate of $6.9 million in the first quarter 2012. Par recorded $5.3 million of net sales in the last six weeks of the fourth quarter following the completion of the Anchen acquisition. |
Published on Friday 18th of May 2012 02:23:11 PM
Read more...
Transcept Prices Public Offering of Common Stock - MarketWatch (press release)
Posted by admin / Under ZolpidemTranscept Prices Public Offering of Common Stock MarketWatch (press release) In the event that Transcept decides to exercise its option to co-promote Intermezzo® (zolpidem tartrate) sublingual tablet C-IV to psychiatrists in the United States, it may use a portion of the net proceeds to support such commercial launch. |
Published on Friday 18th of May 2012 02:23:11 PM
Read more...
